Aims

• to prevent the development of cancer
• to improve patients’ chances of successful recovery
• to limit the physical, psychological and social side-effects of cancer

Main Fields of Activity

• Research
• Prevention
• Patient support

Activities within CAM at the Danish Cancer Society

The main activities within CAM are:

Written by Vinjar Fønnebø and Edzard Ernst, and the CAM-Cancer Consortium. 
Updated March 11, 2011

Use of placebo in cancer research

By Vinjar Fønnebø, NAFKAM, University of Tromsø, Norway and Edzard Ernst, Complementary Medicine, Peninsula Medical School, Universities of Exeter & Plymouth, UK

When confronted with a cancer patient, the health professional faces several treatment challenges, some of them involve the use of CAM in one form or another.

AGSMO is part of the German Cancer Society and has established a group which is in charge of the topic "CAM in supportive/rehabilitation oncology".

Chairs: Matthias Rostock and Markus Horneber

The Centre for Complementary Medicine Research at the University Hospital ‘rechts der Isar’ of Technische Universität München can look back on more than 20 years of history. With effect from January 1, 2010, a chair of naturopathy and complementary medicine was established by the Faculty of Medicine, and Dieter Melchart, the longstanding leader of the centre, was appointed. It is the only position of this kind at the Bavarian universities and is funded by the Erich Rothenfußer Foundation.

Myeong Soo Lee is Principal Researcher in the Division of Standard Research at the Korea Institute of Oriental Medicine in Daejeon, South Korea and an Honorary University Fellow at the Complementary Medicine group at the Peninsula Medical School in Exeter, UK.

The Integrative Canadian Oncology (ICON) Research Initiative aims to provide a vision and a voice for integrative oncology research in Canada.

Given the increased focus on the integration of evidence-based CAM and conventional cancer treatments, the former CAM and cancer Canadian research team decided to shift its research endeavors to integrative oncology rather than CAM alone.

ICON's objectives are to:

Anticancer Fund: Expanding evidence-based cancer treatment options

The Anticancer Fund is a foundation of public utility providing research-based information on cancer therapies and selectively funding the development of promising therapies.

Our vision

The Anticancer Fund is dedicated to expanding the range of treatment options available to patients, regardless of their commercial value.

The University Hospital Zurich is one of the largest and most important teaching hospitals in Europe. With its 43 departments and institutes, the hospital is renowned for its achievements in health care, research and teaching. The Institute for Complementary and Integrative Medicine has an outpatient clinic and offers various types of consultations for patients with cancer with a focus on acupuncture, phytotherapy and mind/body medicine.